Tilray Exports Medical Cannabis Genetics To The European Union

Europe is going green

PORTUGAL: Tilray, a GMP-certified global leader in medical cannabis research and production, today announced that the company has successfully exported live medical cannabis genetics from its flagship British Columbia, Canada facility to its European Union Campus in Cantanhede, Portugal. The announcement is the first time a company has legally exported live cannabis genetics from North America Read the full article…

Tilray Exports Medical Cannabis Products To New Zealand or Nationwide Distribution

Products currently available in New Zealand include precisely formulated medical cannabis oils containing tetrahydrocannabinol (THC) and cannabidiol (CBD).

CANADA: Tilray, a global leader in medical cannabis research and production, today announced that Tilray medical cannabis products have been successfully exported to New Zealand and are now available for distribution nationwide. The products were produced at Tilray’s federally licensed, Good Manufacturing Practice (GMP)-certified facility in Canada and can be dispensed to any patient with valid Read the full article…

Big Business Starting To Look At Canada’s Newest Industry

Philip Morris is one of many big tobacco concerns eyeing legal weed

UNITED KINGDOM: Twenty years ago, it was vilified as a ‘gateway drug’. Now, cannabis has grown into a big business, with the potential to become even bigger as laws are scheduled to change to reflect shifting social attitudes towards marijuana and investment picks up to take advantage of increased demand. And make no mistake: the Read the full article…

Study: Nearly 7.5 Million Canadians — 26% Of The Population — Consume Cannabis

Canadians love to smoke pot

CANADA:  Nearly 11.5 million Canadians, or 39% of adult-age Canadians have admitted they will be cannabis consumers if Prime Minister Justin Trudeau’s legalization plans for 2018 come to bloom, and as a country, 57% of Canadians are supportive of the Prime Minister’s plan for changing the cannabis laws. This is according to a newly released Read the full article…

Case Series: Topical Cannabis Preparations Associated With Reduced Opioid Use

Topical Cannabis Preparations Associated With Reduced Opioid Use

CANADA: The administration of whole-plant topical cannabis extracts is associated with reduced pain and opioid use in patients suffering from leg and ankle ulcers due to Pyoderma Gangrenosum (PG), according to a series of case reports published online ahead of print in the Journal of Pain Symptom Management. Researchers from the University of Toronto evaluated the impact of topically Read the full article…

Isodiol Announces $25 Million Convertible Financing

Isodiol International Inc. Announces $25,000,000 Convertible Debenture Financing

CANADA: Isodiol, a global cannabis innovator specializing in the development of pharmaceutical and consumer products announces it has signed a convertible debenture financing for $25,000,000 CDN with Alumnia Partners. Marcos Agramont CEO of Isodiol stated, “Our focus remains to grow revenues by developing the Isodiol brand domestically and in international markets.  This funding support allows us to Read the full article…

Tilray Announces Second Facility To Meet Rapidly Growing Global Demand For Medical Cannabis

Total output to increase to 51 metric tonnes annually by end of 2018

CANADA: Tilray Canada Ltd., a global leader in medical cannabis research and production, has announced that it will invest, through an affiliated entity, up to $30 million in a second cultivation and processing facility located in Enniskillen, Ontario. The two facilities will generate a combined production capacity of up to 51 metric tonnes per year, which will Read the full article…

Tokyo Smoke Partners With Aphria To Launch Medical Cannabis

The four strains will launch as a part of a kit ($250), featuring unique Tokyo Smoke packaging, five grams of each strain along with custom crafted black glass jars and special welcome accessories.

CANADA: Tokyo Smoke introduces four medical cannabis strains in collaboration with Aphria, one of Canada’s largest licensed producers of medical marijuana. This is the first time a Canadian consumer brand will partner with a Licensed Producer to launch medical cannabis in Canada, an inaugural event for the lifestyle brand, as well as the Canadian marketplace. Grown and distributed Read the full article…

Tilray Announces Support For Clinical Trial Examining Cannabis And Chronic Lung Disease

Tilray clinical trials progress

CANADA: Tilray, a global leader in medical cannabis research and production, today announced a partnership with the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, one of the world’s premier public academic and research institutions, to study the effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD). The Phase II trial will Read the full article…

The Tragically Hip Partner With Newstrike On Medical Marijuana

THE TRAGICALLY HIP PARTNER WITH NEWSTRIKE ON MEDICAL MARIJUANA

CANADA: Newstrike Resources Ltd. has confirmed that one of Canada’s most iconic group of musical artists, The Tragically Hip, are the investors and partners identified indistinctly as the “band” in the Company’s Filing Statement dated May 18, 2017, filed as part of the recently completed business combination with HPI Holdings Ltd. Newstrike’s common shares are expected to commence Read the full article…